MedTrace Logo

SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir)

NCT04365595 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2021-02-23

No results posted yet for this study

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the current pandemic of coronavirus disease (COVID-19) that can lead to respiratory failure requiring oxygen therapy. Some patients develop acute respiratory distress syndrome (ARDS) and may die despite intensive care therapy. Currently it is unknown a) how fast patients recover after being discharged from hospital and b) what underlying predictors may influence recovery.

Conditions

Interventions

OTHER

Questionnaires, spirometry

Questionnaires targeting health-related quality-of-life, symptoms, anxiety and depression

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Christian F Clarenbach, MD · University of Zurich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-03
Primary Completion
2021-02-17
Completion
2021-02-17

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04365595 on ClinicalTrials.gov